 | • レポートコード：D0804-13710 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、狂犬病ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。狂犬病ワクチンの種類別市場規模（ゴーファー腎細胞ワクチン、フリーズドライベロ細胞ワクチン、一般ベロ細胞ワクチン、ヒト二倍体ワクチン）、用途別市場規模（曝露前予防、曝露後予防、追加投与）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、BCHT、Yisheng、Sanofi、Changsheng、Chengda、Zhongke Biological、VACN、Merck、Hissen、Ningbo Rongan Biological Pharmaceutical、Guangzhou Nuocheng Biological ・地域別グローバル市場分析 2015年-2020年 ・狂犬病ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・狂犬病ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・狂犬病ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・狂犬病ワクチンの南米市場（ブラジル、アルゼンチン） ・狂犬病ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ゴーファー腎細胞ワクチン、フリーズドライベロ細胞ワクチン、一般ベロ細胞ワクチン、ヒト二倍体ワクチン ・用途別分析：曝露前予防、曝露後予防、追加投与 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Vaccin Antirabic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Vaccin Antirabic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Vaccin Antirabic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vaccin Antirabic market has been segmented into
Gopher Kidney Cell Vaccine
Freeze-Dried Vero Cell Vaccine
Common Vero Cell Vaccines
Human Diploid Vaccine
By Application, Vaccin Antirabic has been segmented into:
Pre-exposure Prophylaxis
After Exposure Prophylaxis
Additional Doses
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccin Antirabic market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccin Antirabic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccin Antirabic market.
The report offers in-depth assessment of the growth and other aspects of the Vaccin Antirabic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Vaccin Antirabic Market Share Analysis
Vaccin Antirabic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccin Antirabic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccin Antirabic sales, revenue and market share for each player covered in this report.
The major players covered in Vaccin Antirabic are:
GSK
BCHT
Yisheng
Sanofi
Changsheng
Chengda
Zhongke Biological
VACN
Merck
Hissen
Ningbo Rongan Biological Pharmaceutical
Guangzhou Nuocheng Biological
Among other players domestic and global, Vaccin Antirabic market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccin Antirabic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccin Antirabic, with price, sales, revenue and global market share of Vaccin Antirabic in 2018 and 2019.
Chapter 3, the Vaccin Antirabic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccin Antirabic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Vaccin Antirabic market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Vaccin Antirabic sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Vaccin Antirabic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccin Antirabic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Gopher Kidney Cell Vaccine
1.2.3 Freeze-Dried Vero Cell Vaccine
1.2.4 Common Vero Cell Vaccines
1.2.5 Human Diploid Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccin Antirabic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pre-exposure Prophylaxis
1.3.3 After Exposure Prophylaxis
1.3.4 Additional Doses
1.4 Overview of Global Vaccin Antirabic Market
1.4.1 Global Vaccin Antirabic Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 BCHT
2.2.1 BCHT Details
2.2.2 BCHT Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BCHT SWOT Analysis
2.2.4 BCHT Product and Services
2.2.5 BCHT Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Yisheng
2.3.1 Yisheng Details
2.3.2 Yisheng Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Yisheng SWOT Analysis
2.3.4 Yisheng Product and Services
2.3.5 Yisheng Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Changsheng
2.5.1 Changsheng Details
2.5.2 Changsheng Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Changsheng SWOT Analysis
2.5.4 Changsheng Product and Services
2.5.5 Changsheng Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Chengda
2.6.1 Chengda Details
2.6.2 Chengda Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Chengda SWOT Analysis
2.6.4 Chengda Product and Services
2.6.5 Chengda Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zhongke Biological
2.7.1 Zhongke Biological Details
2.7.2 Zhongke Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zhongke Biological SWOT Analysis
2.7.4 Zhongke Biological Product and Services
2.7.5 Zhongke Biological Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 VACN
2.8.1 VACN Details
2.8.2 VACN Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 VACN SWOT Analysis
2.8.4 VACN Product and Services
2.8.5 VACN Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hissen
2.10.1 Hissen Details
2.10.2 Hissen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hissen SWOT Analysis
2.10.4 Hissen Product and Services
2.10.5 Hissen Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ningbo Rongan Biological Pharmaceutical
2.11.1 Ningbo Rongan Biological Pharmaceutical Details
2.11.2 Ningbo Rongan Biological Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ningbo Rongan Biological Pharmaceutical SWOT Analysis
2.11.4 Ningbo Rongan Biological Pharmaceutical Product and Services
2.11.5 Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Guangzhou Nuocheng Biological
2.12.1 Guangzhou Nuocheng Biological Details
2.12.2 Guangzhou Nuocheng Biological Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Guangzhou Nuocheng Biological SWOT Analysis
2.12.4 Guangzhou Nuocheng Biological Product and Services
2.12.5 Guangzhou Nuocheng Biological Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Vaccin Antirabic Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Vaccin Antirabic Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccin Antirabic Manufacturer Market Share in 2019
3.3.2 Top 6 Vaccin Antirabic Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Vaccin Antirabic Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccin Antirabic Sales and Market Share by Regions (2015-2020)
4.1.2 Global Vaccin Antirabic Revenue and Market Share by Regions (2015-2020)
4.2 North America Vaccin Antirabic Sales and Growth Rate (2015-2020)
4.3 Europe Vaccin Antirabic Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccin Antirabic Sales and Growth Rate (2015-2020)
4.5 South America Vaccin Antirabic Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Vaccin Antirabic Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Vaccin Antirabic Sales, Revenue and Market Share by Country
5.1.1 North America Vaccin Antirabic Sales and Market Share by Country (2015-2020)
5.1.2 North America Vaccin Antirabic Revenue and Market Share by Country (2015-2020)
5.2 United States Vaccin Antirabic Sales and Growth Rate (2015-2020)
5.3 Canada Vaccin Antirabic Sales and Growth Rate (2015-2020)
5.4 Mexico Vaccin Antirabic Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Vaccin Antirabic Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccin Antirabic Sales and Market Share by Country (2015-2020)
6.1.2 Europe Vaccin Antirabic Revenue and Market Share by Country (2015-2020)
6.2 Germany Vaccin Antirabic Sales and Growth Rate (2015-2020)
6.3 UK Vaccin Antirabic Sales and Growth Rate (2015-2020)
6.4 France Vaccin Antirabic Sales and Growth Rate (2015-2020)
6.5 Russia Vaccin Antirabic Sales and Growth Rate (2015-2020)
6.6 Italy Vaccin Antirabic Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Vaccin Antirabic Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Vaccin Antirabic Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Vaccin Antirabic Revenue and Market Share by Regions (2015-2020)
7.2 China Vaccin Antirabic Sales and Growth Rate (2015-2020)
7.3 Japan Vaccin Antirabic Sales and Growth Rate (2015-2020)
7.4 Korea Vaccin Antirabic Sales and Growth Rate (2015-2020)
7.5 India Vaccin Antirabic Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccin Antirabic Sales and Growth Rate (2015-2020)
7.7 Australia Vaccin Antirabic Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Vaccin Antirabic Sales, Revenue and Market Share by Country
8.1.1 South America Vaccin Antirabic Sales and Market Share by Country (2015-2020)
8.1.2 South America Vaccin Antirabic Revenue and Market Share by Country (2015-2020)
8.2 Brazil Vaccin Antirabic Sales and Growth Rate (2015-2020)
8.3 Argentina Vaccin Antirabic Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Vaccin Antirabic Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Vaccin Antirabic Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Vaccin Antirabic Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Vaccin Antirabic Sales and Growth Rate (2015-2020)
9.3 Turkey Vaccin Antirabic Sales and Growth Rate (2015-2020)
9.4 Egypt Vaccin Antirabic Sales and Growth Rate (2015-2020)
9.5 South Africa Vaccin Antirabic Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Vaccin Antirabic Sales and Market Share by Type (2015-2020)
10.2 Global Vaccin Antirabic Revenue and Market Share by Type (2015-2020)
10.3 Global Vaccin Antirabic Price by Type (2015-2020)
11 Global Vaccin Antirabic Market Segment by Application
11.1 Global Vaccin Antirabic Sales Market Share by Application (2015-2020)
11.2 Global Vaccin Antirabic Revenue Market Share by Application (2015-2020)
11.3 Global Vaccin Antirabic Price by Application (2015-2020)
12 Market Forecast
12.1 Global Vaccin Antirabic Sales, Revenue and Growth Rate (2021-2025)
12.2 Vaccin Antirabic Market Forecast by Regions (2021-2025)
12.2.1 North America Vaccin Antirabic Market Forecast (2021-2025)
12.2.2 Europe Vaccin Antirabic Market Forecast (2021-2025)
12.2.3 Asia-Pacific Vaccin Antirabic Market Forecast (2021-2025)
12.2.4 South America Vaccin Antirabic Market Forecast (2021-2025)
12.2.5 Middle East & Africa Vaccin Antirabic Market Forecast (2021-2025)
12.3 Vaccin Antirabic Market Forecast by Type (2021-2025)
12.3.1 Global Vaccin Antirabic Sales Forecast by Type (2021-2025)
12.3.2 Global Vaccin Antirabic Market Share Forecast by Type (2021-2025)
12.4 Vaccin Antirabic Market Forecast by Application (2021-2025)
12.4.1 Global Vaccin Antirabic Sales Forecast by Application (2021-2025)
12.4.2 Global Vaccin Antirabic Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Vaccin Antirabic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccin Antirabic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccin Antirabic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Vaccin Antirabic Major Business
Table 9. GSK Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 10. GSK SWOT Analysis
Table 11. GSK Vaccin Antirabic Product and Services
Table 12. GSK Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. BCHT Basic Information, Manufacturing Base and Competitors
Table 14. BCHT Vaccin Antirabic Major Business
Table 15. BCHT Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 16. BCHT SWOT Analysis
Table 17. BCHT Vaccin Antirabic Product and Services
Table 18. BCHT Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Yisheng Basic Information, Manufacturing Base and Competitors
Table 20. Yisheng Vaccin Antirabic Major Business
Table 21. Yisheng Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 22. Yisheng SWOT Analysis
Table 23. Yisheng Vaccin Antirabic Product and Services
Table 24. Yisheng Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Vaccin Antirabic Major Business
Table 27. Sanofi Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Vaccin Antirabic Product and Services
Table 30. Sanofi Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Changsheng Basic Information, Manufacturing Base and Competitors
Table 32. Changsheng Vaccin Antirabic Major Business
Table 33. Changsheng Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 34. Changsheng SWOT Analysis
Table 35. Changsheng Vaccin Antirabic Product and Services
Table 36. Changsheng Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Chengda Basic Information, Manufacturing Base and Competitors
Table 38. Chengda Vaccin Antirabic Major Business
Table 39. Chengda Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 40. Chengda SWOT Analysis
Table 41. Chengda Vaccin Antirabic Product and Services
Table 42. Chengda Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Zhongke Biological Basic Information, Manufacturing Base and Competitors
Table 44. Zhongke Biological Vaccin Antirabic Major Business
Table 45. Zhongke Biological Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 46. Zhongke Biological SWOT Analysis
Table 47. Zhongke Biological Vaccin Antirabic Product and Services
Table 48. Zhongke Biological Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. VACN Basic Information, Manufacturing Base and Competitors
Table 50. VACN Vaccin Antirabic Major Business
Table 51. VACN Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 52. VACN SWOT Analysis
Table 53. VACN Vaccin Antirabic Product and Services
Table 54. VACN Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck Basic Information, Manufacturing Base and Competitors
Table 56. Merck Vaccin Antirabic Major Business
Table 57. Merck Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 58. Merck SWOT Analysis
Table 59. Merck Vaccin Antirabic Product and Services
Table 60. Merck Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Hissen Basic Information, Manufacturing Base and Competitors
Table 62. Hissen Vaccin Antirabic Major Business
Table 63. Hissen Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 64. Hissen SWOT Analysis
Table 65. Hissen Vaccin Antirabic Product and Services
Table 66. Hissen Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Ningbo Rongan Biological Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Major Business
Table 69. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 70. Ningbo Rongan Biological Pharmaceutical SWOT Analysis
Table 71. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Product and Services
Table 72. Ningbo Rongan Biological Pharmaceutical Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Guangzhou Nuocheng Biological Basic Information, Manufacturing Base and Competitors
Table 74. Guangzhou Nuocheng Biological Vaccin Antirabic Major Business
Table 75. Guangzhou Nuocheng Biological Vaccin Antirabic Total Revenue (USD Million) (2018-2019)
Table 76. Guangzhou Nuocheng Biological SWOT Analysis
Table 77. Guangzhou Nuocheng Biological Vaccin Antirabic Product and Services
Table 78. Guangzhou Nuocheng Biological Vaccin Antirabic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Vaccin Antirabic Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Vaccin Antirabic Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Vaccin Antirabic Sales by Regions (2015-2020) (K Units)
Table 82. Global Vaccin Antirabic Sales Market Share by Regions (2015-2020)
Table 83. Global Vaccin Antirabic Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Vaccin Antirabic Sales by Countries (2015-2020) (K Units)
Table 85. North America Vaccin Antirabic Sales Market Share by Countries (2015-2020)
Table 86. North America Vaccin Antirabic Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Vaccin Antirabic Revenue Market Share by Countries (2015-2020)
Table 88. Europe Vaccin Antirabic Sales by Countries (2015-2020) (K Units)
Table 89. Europe Vaccin Antirabic Sales Market Share by Countries (2015-2020)
Table 90. Europe Vaccin Antirabic Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Vaccin Antirabic Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Vaccin Antirabic Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Vaccin Antirabic Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Vaccin Antirabic Sales by Countries (2015-2020) (K Units)
Table 95. South America Vaccin Antirabic Sales Market Share by Countries (2015-2020)
Table 96. South America Vaccin Antirabic Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Vaccin Antirabic Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Vaccin Antirabic Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Vaccin Antirabic Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Vaccin Antirabic Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Vaccin Antirabic Revenue Market Share by Countries (2015-2020)
Table 102. Global Vaccin Antirabic Sales by Type (2015-2020) (K Units)
Table 103. Global Vaccin Antirabic Sales Share by Type (2015-2020)
Table 104. Global Vaccin Antirabic Revenue by Type (2015-2020) (USD Million)
Table 105. Global Vaccin Antirabic Revenue Share by Type (2015-2020)
Table 106. Global Vaccin Antirabic Sales by Application (2015-2020) (K Units)
Table 107. Global Vaccin Antirabic Sales Share by Application (2015-2020)
Table 108. Global Vaccin Antirabic Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Vaccin Antirabic Market Share Forecast by Regions (2021-2025)
Table 110. Global Vaccin Antirabic Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Vaccin Antirabic Market Share Forecast by Type (2021-2025)
Table 112. Global Vaccin Antirabic Sales Forecast by Application (2021-2025)
Table 113. Global Vaccin Antirabic Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Vaccin Antirabic Picture
Figure 2. Global Sales Market Share of Vaccin Antirabic by Type in 2019
Figure 3. Gopher Kidney Cell Vaccine Picture
Figure 4. Freeze-Dried Vero Cell Vaccine Picture
Figure 5. Common Vero Cell Vaccines Picture
Figure 6. Human Diploid Vaccine Picture
Figure 7. Vaccin Antirabic Sales Market Share by Application in 2018
Figure 8. Pre-exposure Prophylaxis Picture
Figure 9. After Exposure Prophylaxis Picture
Figure 10. Additional Doses Picture
Figure 11. Global Vaccin Antirabic Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Vaccin Antirabic Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Vaccin Antirabic Sales Market Share by Manufacturer in 2019
Figure 32. Global Vaccin Antirabic Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Vaccin Antirabic Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Vaccin Antirabic Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Vaccin Antirabic Revenue Market Share by Regions (2015-2020)
Figure 39. Global Vaccin Antirabic Revenue Market Share by Regions in 2018
Figure 40. North America Vaccin Antirabic Sales and Growth Rate (2015-2020)
Figure 41. Europe Vaccin Antirabic Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Vaccin Antirabic Sales and Growth Rate (2015-2020)
Figure 43. South America Vaccin Antirabic Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Vaccin Antirabic Sales and Growth Rate (2015-2020)
Figure 45. North America Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Vaccin Antirabic Sales Market Share by Countries (2015-2020)
Figure 47. North America Vaccin Antirabic Sales Market Share by Countries in 2018
Figure 48. North America Vaccin Antirabic Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Vaccin Antirabic Revenue Market Share by Countries in 2018
Figure 50. United States Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Vaccin Antirabic Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Vaccin Antirabic Revenue Market Share by Countries in 2019
Figure 56. Germany Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Vaccin Antirabic Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Vaccin Antirabic Revenue Market Share by Regions 2019
Figure 64. China Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Vaccin Antirabic Sales Market Share by Countries in 2019
Figure 71. South America Vaccin Antirabic Revenue Market Share by Countries in 2019
Figure 72. Brazil Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Vaccin Antirabic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Vaccin Antirabic Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Vaccin Antirabic Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Vaccin Antirabic Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Vaccin Antirabic Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Vaccin Antirabic Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Vaccin Antirabic Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Vaccin Antirabic Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Vaccin Antirabic Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Vaccin Antirabic Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Vaccin Antirabic Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Vaccin Antirabic Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
ペットワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pet Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pet Vaccine market report provide…- ダニ媒介性脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tick-borne Encephalitis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tick-borne En…
- 帯状疱疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Shingles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Shingles Vaccine market repo…
- mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- mRNAワクチン及び治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…